In this review:
Low-dose IL-2 for primary Sjögren’s syndrome
Turmeric extracts for osteoarthritis
Herpes zoster incidence with upadacitinib
Diagnostic delay and switching biologic DMARDs in SpA
Drug survival rates of biologic DMARDs and small molecules
Vaccination in Australian patients with inflammatory arthritis
Nintedanib for systemic sclerosis-associated interstitial lung disease
Early vs late allopurinol initiation for acute gout
Determinants of health-related quality of life in rheumatoid arthritis
Pain catastrophising and remission in rheumatoid arthritis
Please login below to download this issue (PDF)